Holen Sie sich die Stockscreener-App
1.67
6.96%
-0.125
Vorhandelsmarkt:
1.71
0.04
+2.40%
Schlusskurs vom Vortag:
$1.795
Offen:
$1.81
24-Stunden-Volumen:
54,783
Relative Volume:
2.83
Marktkapitalisierung:
$5.32M
Einnahmen:
$8,700
Nettoeinkommen (Verlust:
$-8.49M
KGV:
-0.3387
EPS:
-4.9303
Netto-Cashflow:
$-7.39M
1W Leistung:
-15.66%
1M Leistung:
-15.66%
6M Leistung:
-37.69%
1J Leistung:
-54.25%
1-Tages-Spanne:
$1.63
$1.8343
1-Wochen-Bereich:
$1.63
$1.98
52-Wochen-Spanne:
$1.63
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
Firmenname
Heartsciences Inc
Sektor
Branche
Telefon
682-237-7781
Adresse
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
1.67 | 5.72M | 8,700 | -8.49M | -7.39M | -4.9303 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Heartsciences Inc Aktie (HSCS) Neueste Nachrichten
HeartSciences Inc. (HSCS) Slides 6.96% as Stock Approaches Critical Support at $1.59Mean Reversion Trade - thelegaladvocate.com
HeartSciences Inc. (HSCS) Declines Over 7% as Stock Tests Key Support Near $1.70Early Entry Signals - thelegaladvocate.com
HeartSciences Inc. (HSCS) Slips 2.5% as Shares Test Key Support ZoneProfit Surge Picks - thelegaladvocate.com
HeartSciences Inc. Warrant (HSCSW) Slides 15.50% as Price Narrows to $0.05TPO Profile - thelegaladvocate.com
HeartSciences Inc. Warrant (HSCSW) Slides 15% as Price Hovers at Key $0.05 LevelPut Flow Alert - thelegaladvocate.com
HeartSciences Inc. (HSCS) Q1 2026 Earnings: Wider-Than-Expected Loss Narrows on Strong Cost Control, Shares RallyAdjusted Earnings Analysis - thelegaladvocate.com
HSCS Q1 2026 Earnings: EPS Surpasses Estimates as HeartSciences Advances Development PipelineEarnings Growth Analysis - newsline.com
HeartSciences signs North Shore Health for MyoVista platform - Investing.com UK
HeartSciences signs North Shore Health for MyoVista platform By Investing.com - Investing.com Nigeria
Rural Minnesota hospital adopts AI ECG platform endorsed by 127-hospital network - Stock Titan
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network - marketscreener.com
HeartSciences Stockholders Approve Director Election and Equity Plan - TipRanks
What HeartSciences HSCS accounting reveals about the business Q1 2026 EPS Tops ViewsRestructuring - Newser
HeartSciences (HSCS) Reports Strong Q1 2026 — Revenue $N/A, EPS BeatsMarket Hype Signals - newser.com
TradingKey - TradingKey
HeartSciences (HSCS) Stock: Slides -3.53%, Support at $1.74 2026-05-14Gamma Alerts - Newser
HeartSciences (HSCSW) Stalls at $$0.06 — Breakout or Breakdown? 2026-05-14Collaborative Trading Signals - newser.com
What HeartSciences (HSCS) accounting reveals about the business | Q1 2026: EPS Tops ViewsCommunity Volume Signals - newser.com
What HeartSciences (HSCSW) disclosed about liquidity position | HSCSW Q3 Earnings: HeartSciences Warrant Shows No Revenue DataEarnings Risk - Newser
HSCSW Q3 Earnings: HeartSciences Warrant Shows No Revenue DataCFO Commentary Report - thelegaladvocate.com
The technology investments behind HeartSciences (HSCSW) growth | HSCSW Q1 Earnings: HeartSciences Revenue Data UnavailableFinancial Health - Newser
HSCSW HeartSciences quarterly results show strategic progress as innovation pipeline drives growth, CEO upbeat on outlook.Cyclicality - newser.com
HeartSciences Inc. 2026 Annual Meeting 8-K Filing: Company Details, Stockholder Votes, and Corporate Governance Updates - Minichart
HeartSciences (NASDAQ: HSCS) 2026 meeting backs director, auditor, adjournment - Stock Titan
HeartSciences signs first SaaS revenues agreement following full launch of MyoVista Insights(TM) - marketscreener.com
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™ - The Manila Times
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights - Weekly Voice
Heartsciences Signs First Saas Revenues Agreement Following Full Launch Of Myovista Insights - TradingView
Colorado hospital becomes first paying MyoVista Insights customer - Stock Titan
Heartsciences Signs Commercial Agreement with St. Vincent Health for MyoVista Insights SaaS Deployment - marketscreener.com
HeartSciences (HSCS) Detailed Report | Q1 2026: EPS Tops ViewsDirect Listing - Cổng thông tin điện tử tỉnh Lào Cai
HSCS (HeartSciences Inc.) reports narrower Q1 2026 loss than analyst estimates even as yearly revenue falls sharply, lifting its shares modestly.Debt Refinancing - UBND thành phố Hải Phòng
HSCS (HeartSciences) shares drop 3.2 percent despite Q1 2026 EPS beat as revenue plummets year over year.Dividend Suspension - Cổng thông tin điện tử tỉnh Tây Ninh
HeartSciences (HSCS) Stock Prediction: What’s Next After Recent Move (Breakdown Watch) 2026-04-20Social Investment Platform - Xã Vĩnh Công
HeartSciences (HSCS) Stock: Why Options Traders Watch It (Marginal Gain) 2026-04-15Insider Selling - Cổng thông tin điện tử Tỉnh Sơn La
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting - 富途牛牛
HeartSciences shareholders have until April 29 to vote online - Stock Titan
Growth Report: Does HeartSciences Inc offer margin of safety2026 Snapshot & Safe Entry Trade Reports - baoquankhu1.vn
Can HeartSciences (HSCS) Stock Reach New Highs | Price at $2.29, Up 0.66%Spring Pattern - thelegaladvocate.com
Is HeartSciences (HSCS) Stock Slowing Down | Price at $2.26, Down 1.74%Call Resistance - thelegaladvocate.com
HeartSciences Announces Passing of COO Mark Hilz; No Changes to Product Plans or Leadership Structure - Minichart
HeartSciences reports passing of COO Mark Hilz, will not seek immediate replacement - Investing.com Australia
HeartSciences COO and Longtime Board Member Passes Away - TipRanks
HeartSc's COO Mark Hilz dies; served on board since 2013 - TradingView
Finanzdaten der Heartsciences Inc-Aktie (HSCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):